IAM
BMY icon

Impax Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Impax Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,996
Closed -$892K – 188
2017
Q3 		$892K Buy
13,996
+1,000
+8% +$58.4K 0.05% 148
2017
Q2 		$724K Buy
12,996
+1,200
+10% +$65.3K 0.04% 148
2017
Q1 		$641K Buy
11,796
+800
+7% +$43.9K 0.04% 154
2016
Q4 		$643K Buy
10,996
+400
+4% +$21.9K 0.04% 152
2016
Q3 		$571K Sell
10,596
-4,812
-31% -$309K 0.03% 152
2016
Q2 		$1.13M Sell
15,408
-40,300
-72% -$2.85M 0.07% 141
2016
Q1 		$3.56M Buy
55,708
+1,361
+3% +$85.8K 0.19% 118
2015
Q4 		$3.74M Buy
54,347
+5,229
+11% +$346K 0.21% 109
2015
Q3 		$2.91M Sell
49,118
-4,717
-9% -$299K 0.17% 113
2015
Q2 		$3.58M Buy
53,835
+932
+2% +$61.4K 0.19% 116
2015
Q1 		$3.41M Buy
52,903
+282
+0.5% +$17.7K 0.19% 116
2014
Q4 		$3.11M Buy
52,621
+5,760
+12% +$325K 0.18% 113
2014
Q3 		$2.4M Buy
46,861
+41,481
+771% +$2.07M 0.16% 118
2014
Q2 		$261K Buy
+5,380
New +$265K 0.02% 180

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Impax Asset Management's BMY Position: Q4 2017 in Review

Impax Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 13,996 shares — an estimated $892K sold.

Impax Asset Management first reported a position in BMY in Q2 2014 and held it in 14 quarters. The position peaked at $3.74M in Q4 2015. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Impax Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
  • Impax Asset Management sold 13,996 Bristol-Myers Squibb shares in Q4 2017, an estimated $892K.
  • Impax Asset Management first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 14 quarters.
  • Impax Asset Management's Bristol-Myers Squibb position peaked at $3.74M in Q4 2015.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Impax Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.